Parks AL, Lykken JM, Rieu-Werden ML, Ko D, et al. Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid Therapy. Neurology 2026;106:e214489.
PMID: 41461060